1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Market Outlook
3.2. Drug Class Outlook
3.3. Application Outlook
3.4. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Critical Care Therapeutics Market, By Drug Class

6.1. Introduction
6.2. Albumin
6.3. Antithrombin Concentrates
6.4. Factor XIII Concentrates
6.5. Fibrinogen Concentrates
6.6. Prothrombin Complex Concentrates

7. United States Critical Care Therapeutics Market, By Application

7.1. Introduction
7.2. Acute Coronary Syndrome
7.3. Atrial Fibrillation
7.4. Coronary Angioplasty
7.5. Deep Vein Thrombosis
7.6. Hemodialysis
7.7. Pulmonary Embolism (PE)
7.8. Surgeries

8. 360iResearch Competitive Strategic Window

8.1. Introduction
8.2. 360iResearch Competitive Strategic Window, by Drug Class
8.3. 360iResearch Competitive Strategic Window, by Application

9. Competitive Landscape

9.1. 360iResearch FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. 360iResearch Market Ranking Analysis
9.3. 360iResearch Market Share Analysis
9.4. 360iResearch Competitive Scenario
9.4.1. Merger & Acquisition
9.4.2. Agreement, Collaboration, & Partnership
9.4.3. New Product Launch & Enhancement
9.4.4. Investment & Funding
9.4.5. Award, Recognition, & Expansion

10. Company Usability Profiles

10.1. Albumedix
10.2. CSL Behring
10.3. Grifols
10.4. Kedrion Biopharma
10.5. Octapharma

11. Appendix

11.1. Discussion Guide
11.2. Edition Details
11.3. License Details
11.4. Pricing Details

List of Figures

FIGURE 1. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CRITICAL CARE THERAPEUTICS MARKET, BY TYPE
FIGURE 7. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 8. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 10. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 11. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025
FIGURE 14. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 15. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

List of Tables

TABLE 1. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY ALBUMIN, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY ANTITHROMBIN CONCENTRATES, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY FACTOR XIII CONCENTRATES, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY FIBRINOGEN CONCENTRATES, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATES, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY ATRIAL FIBRILLATION, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY CORONARY ANGIOPLASTY, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY HEMODIALYSIS, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY PULMONARY EMBOLISM (PE), 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY SURGERIES, 2017-2025 (USD MILLION)
TABLE 14. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: SCORES
TABLE 15. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 16. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 17. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: RANKING
TABLE 18. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 19. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 20. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 21. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 22. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 23. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: EDITION DETAILS
TABLE 24. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: LICENSE DETAILS
TABLE 25. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET: PRICING DETAILS

Companies Mentioned

Albumedix
CSL Behring
Grifols
Kedrion Biopharma
Octapharma